| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC22043 | BTZO-2 | BTZO-2 is an active BTZO-1 derivative, an antioxidant response element-activator, provides protection against lethal endotoxic shock in mice.. |
|
| DC10945 | BU09059 | BU09059 is a potent, selective, short-acting kappa-opioid receptor antagonist with Ki of 1.72 nM, displays 15- and 616-fold selectivity over μ- and δ-receptors respectively. |
|
| DCAPI1209 | Budesonide | Budesonide |
|
| DC6501 | Bufalin Featured | Bufalin inhibits steroid receptor coactivator 1 (SRC-1) and SRC-3 at doses as low as 5 nM, promotes the degradation of SRC-3 protein, and inhibits cancer cell growth both in vitro and in vivo. |
|
| DCAPI1160 | Buflomedil HCl | Buflomedil HCl |
|
| DCAPI1140 | Bumetanide Featured | Bumetanide |
|
| DC9360 | Buparvaquone | Buparvaquone(Butalex) is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone; it is a promising compound for the therapy and prophylaxis of all forms of theileriosis. |
|
| DCAPI1459 | Bupivacaine HCL | Bupivacaine HCL |
|
| DC22437 | Burimamide oxalate | Burimamide oxalate is a potent dual H3/H2 receptor antagonist with Ki of 0.07 and 7.8 uM, respectively. |
|
| DC20059 | Burixafor hydrobromide (TG-0054 hydrobromide) | Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent antagonist of CXCR4 and a well water soluble anti-angiogenic drug that is of potential value in treating choroid neovascularization. Burixafor hydrobromide (TG-0054 hydrobr |
|
| DC8995 | Busulfan/Myleran | Busulfan is a bifunctional alkylating agent. |
|
| DC11381 | Butabindide (oxalate) Featured | Butabindide is a potent inhibitor of cholecystokinin-inactivating peptidase/tripeptidyl peptidase 2 (CCK-inactivating peptidase/TPP-2; Ki = 7 nM).1 It is selective for CCK-inactivating peptidase/TPP-2 over a panel of serine proteases (Kis = >1 μM) as well as CCK receptors (Kis = >0.1 mM). |
|
| DCAPI1407 | Butenafine | Butenafine |
|
| DC10693 | O-Butyryl timolol Featured | Butyryltimolol is a lipophilic ester prodrug of timolol, a beta adrenergic blocer with antihypertensive and hemodynamic properties. |
|
| DC7563 | BV6 Featured | BV6 induced apoptotic and necrotic cell death in monocytes while T-cells, dendritic cells and macrophages were largely protected against BV6-induced cell death. |
|
| DC8089 | BVT 2733(BVT.2733) Featured | BVT 2733 is a selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor,protecting osteoblasts against endogenous glucocorticoid induced dysfunction. |
|
| DC8278 | BVT-14225 Featured | BVT 14225 is a new selective 11b-HSD1 inhibitor, it belongs to a class of arylsulfonamidothiazoles with in vitro and in vivo antidiabetic effects |
|
| DC21685 | BVT-948 Featured | BVT-948 (SPS8I-3) is a noncompetitive, cell-permeable inhibitor of protein tyrosine phosphatases (PTPs) with IC50 of 0.09-1.7 uM. Results show that the effect of BVT948 (BVT.948) is to strengthen the insulin signal and has no effects on the duration of th |
|
| DC12041 | BW-A 78U Featured | BW-A 78U is a PDE4 inhibitor with an IC50 of 3 μM. |
|
| DC20852 | BX-320 | BX-320 is a potent, selective and ATP-competitive inhibitor of PDK1 with IC50 of 30 nM, >20-fold selectivity over PKA. |
|
| DC7675 | BX-471（ZK 811752） Featured | BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1); exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4. |
|
| DC8808 | BX-513 hydrochloride Featured | BX-513 hydrochloride inhibits MIP-1α-induced intracellular calcium mobilization (IC50 = 2.5 μM). |
|
| DC8062 | BX517 Featured | BX517 is a novel phosphoinositide-dependent kinase-1 (PDK1) inhibitor. |
|
| DC22424 | BX-667 | BX-667 is a potent P2Y12 receptor antagonist that blocks ADP-induced platelet aggregation in human, dog and rat blood (IC50=97, 317 and 3000 nM respectively). |
|
| DC7092 | BX795 Featured | BX795 is a potent and selective dual inhibitor of TBK1/PDK1 with IC50s of 2 nM/6 nM respectively; > 50 fold selectivity over PKA, PKC, c-Kit, GSK3β etc. |
|
| DC7093 | BX912 Featured | BX-912 is a selective inhibitor of 3-Phosphoinositide-dependent Kinase-1 (PDK1) with IC50 of 12 nM; >10 fold selectivity over PKA, PKC, C-Kit, EGFR etc. |
|
| DC11219 | BXI-72 Featured | BXI-72 (NSC334072) is a potent, selective small molecule Bcl-XL inhibitor that targets the BH3 domain of Bcl-XL (Kd=0.9 nM). |
|
| DC11058 | BYK191023 | BYK191023 (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM, >20-fold selectivity over nNOS and eNOS (IC50=17 and 162 uM). |
|
| DC11059 | BYK191023 dihydrochloride | BYK191023 dihydrochloride (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM, >20-fold selectivity over nNOS and eNOS (IC50=17 and 162 uM). |
|
| DC7094 | Alpelisib(BYL-719) Featured | BYL719 is a potent and selective PI3Kα inhibitor with IC50 of 5 nM, ;liitle or no effect on PI3Kβ/γ/δ. |
|
